ASX - By Stock
|
SPL |
Re:
Starpharma has never been in a better place fundamentally
|
|
solotraveller
|
21 |
4.6K |
1 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
21
|
4.6K
|
1
|
|
ASX - By Stock
|
SPL |
another BV startup
|
|
solotraveller
|
2 |
818 |
2 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
2
|
818
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Fed up with the low share price?
|
|
solotraveller
|
68 |
16K |
2 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
68
|
16K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma receives $7.7M R&D tax incentive refund
|
|
solotraveller
|
12 |
3.2K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
12
|
3.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Another nasal spray going to human trials
|
|
solotraveller
|
31 |
9.1K |
6 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
31
|
9.1K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
DEP phase 2 trials - patience required!
|
|
solotraveller
|
9 |
2.9K |
1 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
9
|
2.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
DEP phase 2 trials - patience required!
|
|
solotraveller
|
9 |
2.9K |
2 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
9
|
2.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Media Coverage
|
|
solotraveller
|
45 |
17K |
4 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
45
|
17K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Question
|
|
solotraveller
|
12 |
4.1K |
1 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
12
|
4.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
CEO of Starpharma interviewed by Alan Kohler
|
|
solotraveller
|
83 |
29K |
1 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
83
|
29K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Perking up for Thusday
|
|
solotraveller
|
2 |
652 |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2
|
652
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Salt in wound
|
|
solotraveller
|
13 |
5.3K |
3 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
13
|
5.3K
|
3
|
|
ASX - By Stock
|
SPL |
toilet marketing
|
|
solotraveller
|
1 |
828 |
23 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
1
|
828
|
23
|
|
ASX - By Stock
|
SPL |
Re:
Light the fuse!
|
|
solotraveller
|
10 |
3.3K |
2 |
27/08/19 |
27/08/19 |
ASX - By Stock
|
10
|
3.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Facts and Spin
|
|
solotraveller
|
40 |
12K |
1 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
40
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Facts and Spin
|
|
solotraveller
|
40 |
12K |
1 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
40
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Facts and Spin
|
|
solotraveller
|
40 |
12K |
3 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
40
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: NDA submission for VivaGel BV in the US
|
|
solotraveller
|
37 |
10K |
1 |
27/11/17 |
27/11/17 |
ASX - By Stock
|
37
|
10K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: NDA submission for VivaGel BV in the US
|
|
solotraveller
|
37 |
10K |
0 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
37
|
10K
|
0
|
|